Applied Therapeutics | 4:持股变动声明-高管 Perfetti Riccardo
Applied Therapeutics | 4:持股变动声明-高管 Funtleyder Leslie D.
Applied Therapeutics | 4:持股变动声明-高管 Shendelman Shoshana
Applied Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Shoshana Shendelman(6.6%)
Applied Therapeutics | 144:拟议出售证券
Applied Therapeutics | 10-Q:2024财年二季报
Applied Therapeutics | 8-K:应用疗法公布2024年第二季度财务业绩
Applied Therapeutics | 4:持股变动声明-高管 Shendelman Shoshana
Applied Therapeutics | 4:持股变动声明-高管 Perfetti Riccardo
Applied Therapeutics | 4:持股变动声明-高管 Funtleyder Leslie D.
Applied Therapeutics | 4:持股变动声明-董事 Kanter Stacy J.
Applied Therapeutics | 4:持股变动声明-董事 SKYLER JAY S
Applied Therapeutics | 4:持股变动声明-董事 MARCUS JOEL S
Applied Therapeutics | 4:持股变动声明-董事 Lerner Teena
Applied Therapeutics | 4:持股变动声明-股东 ALEXANDRIA REAL ESTATE EQUITIES, INC.
Applied Therapeutics | 8-K:重大事件
Applied Therapeutics | 144:拟议出售证券
Applied Therapeutics | 144:拟议出售证券
Applied Therapeutics | 144:拟议出售证券
Applied Therapeutics | 144:拟议出售证券
暂无数据
暂无数据